| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |